Languages
Français
English
Leadership
Our Pipeline
Viaskin
™
Peanut
Viaskin
™
Milk
Viaskin
™
Egg
Expanded Access Program
Scientific Publications & Presentations
Viaskin
®
Platform
Investors & Media
Press Releases
Events & Presentations
Financial Information
SEC Filings
AMF Regulated Information
Annual Reports & General Meetings
Stock Information
Investor FAQs
Corporate Governance
Board of Directors
Audit Committee
Compensation Committee
Nominating Committee
Careers
Contact Us
Leadership
Our Pipeline
Viaskin
™
Peanut
Viaskin
™
Milk
Viaskin
™
Egg
Expanded Access Program
Scientific Publications & Presentations
Viaskin
®
Platform
Investors & Media
Press Releases
Events & Presentations
Financial Information
SEC Filings
AMF Regulated Information
Annual Reports & General Meetings
Stock Information
Investor FAQs
Corporate Governance
Board of Directors
Audit Committee
Compensation Committee
Nominating Committee
Careers
Contact Us
Overview
Press Releases
Events & Presentations
Financial Information
SEC Filings
AMF Regulated Information
Annual Reports & General Meetings
Stock Information
Investor FAQs
Corporate Governance
Board of Directors
Audit Committee
Compensation Committee
Nominating Committee
Board of Directors
Daniel Tassé
DBV, Chief Executive Officer
Viviane Monges
Pharmaceutical Executive and Advisor
Torbjörn Bjerke
Portfolio Manager of Arctic Aurora LifeScience and a director of TXP Pharma GmbH
Michel de Rosen
Chairman of the Board
Michael Goller
Partner, Baker Brothers Investments
Claire Giraut
Director, Julius Baer Group Ltd.
Maïlys Ferrere
Director, Head, Large Venture Investment activities, Bpifrance
Julie O’Neill
Pharmaceutical Executive and Advisor
Daniel Soland
Pharmaceutical Executive and Advisor
